Status:
COMPLETED
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
Lead Sponsor:
University of Zagreb
Conditions:
Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Excessive bleeding after cardiopulmonary bypass (CPB) operations remains to be a persistent problem. Antiplatelet therapy (APT) is an integral component of perioperative management in patients undergo...
Detailed Description
Excessive bleeding after cardiopulmonary bypass (CPB) operations remains to be a persistent problem. Antiplatelet therapy (APT) is an integral component of perioperative management in patients undergo...
Eligibility Criteria
Inclusion
- \> 18 years old
- Elective cardiac surgery patients
- Coronary artery disease
- Aortic valve disease
- Mitral valve disease
- Ascendent aorta aneurysm
- Combine coronary and valve disease
- Cardiac surgery procedures using cardiopulmonary bypass
Exclusion
- Missing consent
- Patients with emergent cardiac surgical procedures
- Patients on antiplatelet therapy other than aspirin , clopidogrel and prasugrel
- Patients with inaccurate antiplatelet therapy administration documentation
- Missing data
- Off-pump procedures
- Patients younger than 18 years old
- Patients with severe mental disorders
- Intrinsic coagulopathy
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT02277379
Start Date
September 1 2014
End Date
January 1 2015
Last Update
January 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHC Zagreb
Zagreb, Croatia, 10000